Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2010
10/28/2010WO2010124223A1 Anti-cancer tocotrienol analogues and associated methods
10/28/2010WO2010124201A2 Compositions and methods for treatment of cardiovascular disease
10/28/2010WO2010124175A1 Stable topical compositions for 1,2,4-thiadiazole derivatives
10/28/2010WO2010124141A1 Methods of treating a pulmonary bacterial infection using fluoro-quinolones
10/28/2010WO2010124122A1 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124121A1 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitor
10/28/2010WO2010124120A1 Use of guanethidine for treating hypertension by local vascular delivery
10/28/2010WO2010124119A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124116A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124114A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124112A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124108A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124102A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124100A1 Novel selective 5-ht4 receptor antagonists
10/28/2010WO2010124097A2 Transcription factor modulating compounds and methods of use thereof
10/28/2010WO2010124089A2 Methods for treating dependence
10/28/2010WO2010124086A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124082A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124055A1 2-alkyl piperidine mglur5 receptor modulators
10/28/2010WO2010124047A1 Bisaryl alkynylamides as negative allosteric modulators of metabotropic glutamate receptor 5 (mglur5)
10/28/2010WO2010124039A1 Methods of administering dutasteride
10/28/2010WO2010123999A2 1-methylpyrazole modulators of substance p, calcitonin gene-related peptide, adrenergic receptor, and/or 5-ht receptor
10/28/2010WO2010123997A1 Carbacephem beta-lactam antibiotics
10/28/2010WO2010123996A1 Methods and systems for treating cell proliferation disorders with psoralen derivatives
10/28/2010WO2010123995A1 Bifunctional/polyfunctional dopamine d2/d3 agonist as neuroprotective agents for treatment of neurodegenerative diseases
10/28/2010WO2010123983A1 Compostions and methods for targeted gene therapy
10/28/2010WO2010123975A1 Novel anti-inflammatory agents
10/28/2010WO2010123956A2 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010WO2010123933A1 Compounds, compositions and methods comprising 1,3,4-oxadiazole derivatives
10/28/2010WO2010123931A1 Methods of treatment for solid tumors
10/28/2010WO2010123930A2 Chemosensory receptor ligand-based therapies
10/28/2010WO2010123870A1 Heteroaryl compounds and uses thereof
10/28/2010WO2010123865A2 Two component interactive emulsion product
10/28/2010WO2010123845A2 Siderophore conjugate immunogenic compositions and vaccines
10/28/2010WO2010123844A1 Improved method of achieving and maintaining a specified alkylene oxide production parameter with a high efficiency catalyst
10/28/2010WO2010123838A2 Novel amide and amidine derivatives and uses thereof
10/28/2010WO2010123832A2 2-oxamide inhibitors of phospholipase a2 activity and cellular arachidonate release based on dipeptides and pseudopeptides
10/28/2010WO2010123822A1 Compounds, compositions and methods comprising pyridazine sulfonamide derivatives
10/28/2010WO2010123769A1 Compositions and methods for treating ocular inflammation with lower risk of increased intraocular pressure
10/28/2010WO2010123766A1 DIAMIDE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND β2 ADRENERGIC RECEPTOR AGONIST ACTIVITY
10/28/2010WO2010123648A2 Compositions and methods for the treatment of sepsis and other disorders involving phospholipase a2 induction
10/28/2010WO2010123591A2 Small molecule inhibitors of nads, namnat, and nmnat
10/28/2010WO2010123583A2 1-aryl or 1-heteroaryl-pyrido[b]indoles and uses thereof
10/28/2010WO2010123545A2 Angiogenesis inhibitors
10/28/2010WO2010123527A2 Use of epidermal growth factor inhibitors in the treatment of viral infection
10/28/2010WO2010123507A1 Treatment of non-localized inflammation with pan-hdac inhibitors
10/28/2010WO2010123451A1 Sulphide bridged derivatives as modulators of mglur5
10/28/2010WO2010123443A1 Pharmaceutical composition comprising 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n- propylcinnoline-3-carboxamide hydrogen sulphate.
10/28/2010WO2010123441A1 Crystalline form of 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n-propylcinnoline-3- carboxamide hydrogen sulphate, for treatment of anxiety disorders
10/28/2010WO2010123440A1 Pharmaceutical composition comprising 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n- propylcinnoline-3-carboxamide hydrogen sulphate and rate-controlling polymer
10/28/2010WO2010123337A1 Enrofloxacin complex with maximum residence time in the plasma of mammals and birds
10/28/2010WO2010123221A2 Composition for preventing and improving the symptoms of menopause, containing glyceollins as an active ingredient
10/28/2010WO2010123184A1 Composition for preventing and treating alopecia disorder containing norgalanthamine compounds as an active ingredient
10/28/2010WO2010123156A1 Angiogenesis inhibitor
10/28/2010WO2010123150A1 2-aryl imidazoline derivatives
10/28/2010WO2010123139A1 Arylcarboxamide derivative having sulfamoyl group
10/28/2010WO2010123111A1 1-menthyl (3r)-3-hydroxybutanoate, process for producing same, and composition containing same for stimulating sense
10/28/2010WO2010123110A1 Process for producing 1-menthyl (3s)-3-hydroxybutanoate and composition for stimulating sense
10/28/2010WO2010123103A1 Adhesive patch-containing package bag and method for storing adhesive patch
10/28/2010WO2010123102A1 Collagen production promoter, anti-photoaging agent, moisture-retention improvement agent, and composite for use on skin
10/28/2010WO2010123078A1 Method for predicting therapeutic effect of chemotherapy on renal cell cancer
10/28/2010WO2010123065A1 Cancer antigen helper peptide
10/28/2010WO2010123049A1 Selective ep4 receptor agonistic substance for treatment of cancer
10/28/2010WO2010123047A1 Crystal of benzoxazinone compound
10/28/2010WO2010123018A1 Diazaspiroalkane derivative
10/28/2010WO2010123017A1 Tetrazole compound
10/28/2010WO2010123016A1 Carboxylic acid compound
10/28/2010WO2010123006A1 Pyrrolidine compound
10/28/2010WO2010122980A1 Novel thyroid hormone β receptor agonist
10/28/2010WO2010122979A1 Thiazolidinone derivative
10/28/2010WO2010122968A1 Diacylethylenediamine compound
10/28/2010WO2010122927A1 Pharmaceutical agent for prevention or treatment of retarded nerve regeneration induced by diabetes
10/28/2010WO2010122669A1 Novel compound amycolamicin, method for production thereof, and use thereof
10/28/2010WO2010122538A1 Pharmaceutical compositions for treatment of hcv patients that are non-responders to interferon
10/28/2010WO2010122504A1 Thiazole derivatives and their use as p2y12 receptor antagonists
10/28/2010WO2010122494A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and mometasone, and a process to make it
10/28/2010WO2010122493A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid, and an antifungal agent, and a process to make it
10/28/2010WO2010122492A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a corticosteroid, and a process to make it
10/28/2010WO2010122491A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid, and an antifungal agent, and a process to make it
10/28/2010WO2010122490A2 A medicinal anti diaper rash cream incorporating a biopolymer and a process to make it
10/28/2010WO2010122482A1 Pharmaceutical compositions for the treatment of nasal polyposis
10/28/2010WO2010122478A1 A medicinal antibacterial and steroids cream incorporating a biopolymer and a process to make it
10/28/2010WO2010122477A1 A medicinal antifungal, antibacterial and steroid cream incorporating a biopolymer and a process to make it
10/28/2010WO2010122476A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, miconazole and mometasone, and a process to make it
10/28/2010WO2010122475A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, clotrimazole and mometasone, and a process to make it
10/28/2010WO2010122456A1 Compositions of sulopenem and use for treating tuberculosis
10/28/2010WO2010122453A1 A medicinal cream containing miconazole nitrate, hydrocortisone acetate, and a biopolymer, and a process to make it
10/28/2010WO2010122452A1 A medicinal antifungal and steroid cream incorporating a biopolymer and a process to make it
10/28/2010WO2010122442A1 Paediatric solutions comprising a beta-blocker
10/28/2010WO2010122436A1 Rifamycin derivatives
10/28/2010WO2010122407A2 Hypolipaemic pharmaceutical compositions
10/28/2010WO2010122356A1 Sublingual spray formulation comprising dihydroartemesinin
10/28/2010WO2010122355A1 Sublingual pharmaceutical composition comprising a neutral oil
10/28/2010WO2010122344A1 Novel use
10/28/2010WO2010122343A1 A process for the preparation of frovatriptan and frovatriptan succinate and their synthetic intermediates
10/28/2010WO2010122294A1 Thiophene inhibitors of ikk-b serine-threonine protein kinase
10/28/2010WO2010122276A1 Drug delivery
10/28/2010WO2010122275A1 Pharmaceutical preparation
10/28/2010WO2010122272A1 1-pyrazolo[4,3-c]isoquinoline derivatives, preparation thereof and therapeutic use thereof
10/28/2010WO2010122204A1 Polyarginine nanocapsules
1 ... 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 2043 2044 2045 2046 2047 ... 7860